Cargando…

Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT

Survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for severe idiopathic aplastic anemia (SAA) has improved in recent years, approaching 75% at 5 years. However, an SAA-adapted composite endpoint, graft-versus-host disease (GvHD) and relapse/rejection-free survival (GRFS),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devillier, Raynier, Eikema, Dirk-Jan, Dufour, Carlo, Aljurf, Mahmoud, Wu, Depei, Maschan, Alexei, Kulagin, Alexander, Halkes, Constantijn J. M., Collin, Matthew, Snowden, John, Renard, Cécile, Ganser, Arnold, Sykora, Karl-Walter, Gibson, Brenda E., Maertens, Johan, Itäla-Remes, Maija, Corti, Paola, Cornelissen, Jan, Bornhäuser, Martin, Araujo, Mercedes Colorado, Ozdogu, Hakan, Risitano, Antonio, Socie, Gerard, de Latour, Regis Peffault
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2023
Materias:	Article - Aplastic Anemia
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483355/ https://www.ncbi.nlm.nih.gov/pubmed/36951165 http://dx.doi.org/10.3324/haematol.2022.281876

Ejemplares similares

Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT
por: Risitano, Antonio M., et al.
Publicado: (2019)

Aplastic anemia in adult and pediatric hematology
por: Niemeyer, Charlotte
Publicado: (2019)

The anemias; with special reference to pernicious anemia and the use of liver extracts in the treatment of anemias. Supplement: Blood morphology in diagnosis.
Publicado: (1950)

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis
por: Meadowcroft, Amy M, et al.
Publicado: (2018)

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease
por: Holdstock, Louis, et al.
Publicado: (2018)

Evaluation of changes in ferritin levels during sucroferric oxyhydroxide treatment
por: Koiwa, Fumihiko, et al.
Publicado: (2018)

Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure
por: Caltabiano, Stephen, et al.
Publicado: (2019)

Immunosuppression and stem cell stimulation to treat AA: clinical and biologic implications
por: Young, Neal S.
Publicado: (2019)

Stem cell transplantation in aplastic anemia: Impact on choices for first line therapy
por: Bacigalupo, Andrea, et al.
Publicado: (2019)

Somatic mutations in aplastic anemia: Significance for classification, therapy, and outcome
por: Wood, Henry J., et al.
Publicado: (2019)

Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)
por: Miller, Paul D. E., et al.
Publicado: (2019)

Preventing and controlling iron deficiency anaemia through primary health care: a guide for health administrators and programme managers
por: DeMaeyer, E. M.
Publicado: (1989)

Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study
por: Fein, Joshua A., et al.
Publicado: (2023)

Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
por: Koenecke, Christian, et al.
Publicado: (2022)

Eritropoyetina en hematología /
por: Alegre Amor, Adrián
Publicado: (2005)

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT
por: Pavlů, Jiří, et al.
Publicado: (2019)

Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
por: Raj, Kavita, et al.
Publicado: (2022)

Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
por: Gagelmann, Nico, et al.
Publicado: (2019)

Manual de hematología
Publicado: (1998)

ALTERAÇÕES HEMATOLÓGICAS EM PACIENTES COM COVID-19 HOSPITALIZADOS: ESTUDO RETROSPECTIVO
por: Martins, ML, et al.
Publicado: (2021)

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT
por: Gagelmann, Nico, et al.
Publicado: (2018)

Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation
por: Tichelli, André, et al.
Publicado: (2020)

Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
por: Saccardi, Riccardo, et al.
Publicado: (2023)

Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT
por: Gilleece, Maria H., et al.
Publicado: (2021)

Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
por: Chihara, Dai, et al.
Publicado: (2022)

Anemia y cáncer /
Publicado: (2015)

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus
por: Passweg, Jakob R., et al.
Publicado: (2020)

Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT
por: Poiré, Xavier, et al.
Publicado: (2020)

Physicians Abstracts: EBMT 2010
Publicado: (2010)

Publication only: EBMT 2010
Publicado: (2010)

The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT
por: Tournilhac, Olivier, et al.
Publicado: (2023)

RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT
por: Baron, Frédéric, et al.
Publicado: (2016)

Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
por: Poiré, Xavier, et al.
Publicado: (2017)

Anemia : hematología para un diagnóstico básico
Publicado: (1986)

Novel approaches to oral iron treatment
por: Moretti, Diego
Publicado: (2019)

The diagnostic potential of the iron-regulatory hormone hepcidin
por: Armitage, Andrew E., et al.
Publicado: (2019)

Mechanisms, mishaps and manipulation of iron uptake
por: Bennett, Cavan, et al.
Publicado: (2019)

The first steps towards a diverse and inclusive EBMT: a position paper
por: Montoto, S., et al.
Publicado: (2022)

Handling of Allogeneic HPC Grafts in European Transplant Centers during the COVID-19 Pandemic - a Survey from the Infectious Diseases and Cellular Therapy & Immunobiology Working Parties of the EBMT
por: Worel, Nina, et al.
Publicado: (2022)

Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party
por: Hayden, Patrick J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_25h2u2ke7ov8bn8q2kbeksq1no